Keyphrases
Atypical Teratoid Rhabdoid Tumor (AT/RT)
100%
Tumor Organoids
100%
Vulnerability
100%
Atypical Teratoid
100%
Rhabdoid
100%
Pediatric Brain Tumor
16%
High Sensitivity
16%
Molecular Subgroups
16%
Epigenetics
8%
High-level Expression
8%
SMARCB1
8%
Clinical Features
8%
Treatment Regimen
8%
Organoid Models
8%
Drug Sensitivity
8%
Gene Expression Profile
8%
Clinical Model
8%
Specific Treatment
8%
SWItch/Sucrose Non-fermentable
8%
Chromatin Remodelers
8%
Epigenetic Profile
8%
SMARCA4
8%
Patient-specific Therapy
8%
Notch Inhibitor
8%
Multi-targeted Tyrosine Kinase Inhibitors
8%
High-throughput Drug Screen
8%
Heterogeneous Response
8%
Notch Receptors
8%
Preclinical in Vitro Models
8%
Biochemistry, Genetics and Molecular Biology
Epigenetics
100%
Tyrosine Kinase Inhibitor
50%
Gene Expression
50%
SMARCB1
50%
Chromatin Remodeling
50%
SWI/SNF
50%
Drug Sensitivity
50%
SMARCA4
50%
Neuroscience
Pediatric Brain Tumor
100%
In Vitro
50%
Gene Expression
50%
Chromatin Assembly and Disassembly
50%
Tyrosine Kinase Inhibitor
50%
Receptor
50%
Medicine and Dentistry
Atypical Teratoid Rhabdoid Tumor
100%
Pediatric Brain Tumor
16%
In Vitro
8%
Clinical Feature
8%
Organoid
8%
Gene Expression
8%
Drug Sensitivity
8%
Tyrosine-Kinase Inhibitor
8%
Receptor
8%
Chromatin Remodeling
8%